|
|
|
Fig. 1. Comparison of ionotropic glutamate receptor sequences and NMDA receptor antagonists used in this study. A, Sequence alignment of the M2-M3 regions of GluA1, GluA2, GluN1-1a, GluN2A, GluN3A and GluN3B subunits. Highlighted with â is the Q/R/N site and â is the N + 1 site. Other amino acids of interest are indicated by â² and numbered by their relationship to the N site. Highlighted in black are conserved amino acids. B, 2-D structures of memantine, (+)-MK-801, PhTX-343 and methoctramine.
|
|
Fig. 2. GluN3 subunits are incorporated into the NMDA receptors. A, Effect of subunit composition on steady-state current. Bars represent mean current (error bars are 95% CI, n = 40â85). Significant differences compared to GluN1-1a/2A within a voltage group are indicated above the bars (*P < 0.05 or ***P < 0.001, Bonferroni). B, Glycine does not activate a current in oocytes injected with GluN1-1a, GluN2A and GluN3A. Currents from the same oocyte exposed to glycine alone (1 mM) or NMDA/glycine (100/10 μM). Similar results were obtained from six oocytes from three different batches (Vh = â 50 mV). C,D, I/V relationships for oocytes injected with GluN1-1a/2A (C) or GluN1-1a/2A/3A (D). Current was evoked by application of 100 μM NMDA plus 10 μM glycine, normalised to that at â 75 mV and plotted as mean ± S.E.M. Points between â 50 mV and 0 mV are fit by linear regression.
|
|
Fig. 3. Summary of the IC50 values for Mg2+, memantine, MK-801, PhTX-343 and methoctramine block of the NMDA receptor subunit combinations tested. IC50s were obtained from the concentrationâinhibition curves given in Figs. 4â8 for GluN1-1a/2A, GluN1-1a/2A/3A and GluN1-1a/2A/3B, and in Supplementary Fig. 3 for GluN1-1a/2A/3A(G729N) and GluN1-1a/2A/3A(R730N). Bars show IC50 (μM) ± 95% CI. Numbers in parentheses are the number of oocytes. Statistical comparisons were made with GluN1-1a/2A (*) or with GluN1-1a/2A/3A (â ) with significance of difference accepted for *,â P < 0.05, **,â â P < 0.01, ***,â â â P < 0.001.
|
|
Fig. 4. Characterising the block of GluN3-lacking and GluN3-containing NMDA receptors by Mg2+. AâC, sample traces of currents from Xenopus oocytes injected with GluN1-1A/2A (A), GluN1-1a/2A/3A (B) or GluN1-1a/2A/3B (C) and exposed to 100 μM NMDA plus 10 μM Gly with the addition of increasing concentrations of Mg2+ (10â 8 to 10â 4 M in 10-fold increments) indicated by the arrows, with the last arrow indicating wash. Traces begin 3 s before the lowest Mg2+ concentration was applied by which point a stable current was established; as this was after a variable period the first part of the trace is not shown. All traces were recorded at a Vh of â 75 mV. DâF, concentrationâinhibition curves for Mg2+ block of 100 μM NMDA plus 10 μM Gly currents from Xenopus oocytes injected with GluN1-1A/2A (â, solid line), GluN1-1a/2A/3A (â , broken line) or GluN1-1a/2A/3B (â¦, dotted line). Points are means ± S.E.M. for 6â7 oocytes. Curves are fits to the equation given in the Materials and methods section and IC50s derived from these are given in Fig. 3.
|
|
Fig. 5. Characterising the block of GluN3-lacking and GluN3-containing NMDA receptors by memantine. AâC, sample traces of currents from Xenopus oocytes injected with GluN1-1A/2A (A), GluN1-1a/2A/3A (B) or GluN1-1a/2A/3B (C) and exposed to 100 μM NMDA plus 10 μM Gly with the addition of increasing concentrations of memantine (10â 8 to 10â 4 M in 10-fold increments) indicated by the arrows, with the last arrow indicating wash. Traces begin 3 s before the lowest memantine concentration was applied by which point a stable current was established; as this was after a variable period the first part of the trace is not shown. All traces were recorded at a Vh of â 75 mV. DâF, concentrationâinhibition curves for memantine block of 100 μM NMDA plus 10 μM Gly currents from Xenopus oocytes injected with GluN1-1A/2A (â, solid line), GluN1-1a/2A/3A (â , broken line) or GluN1-1a/2A/3B (â¦, dotted line). Points are means ± S.E.M. for 6â9 oocytes. Curves are fits to the equation given in the Materials and methods section and IC50s derived from these are given in Fig. 3.
|
|
Fig. 6. Characterising the block of GluN3-lacking and GluN3-containing NMDA receptors by MK-801. AâC, sample traces of currents from Xenopus oocytes injected with GluN1-1A/2A (A), GluN1-1a/2A/3A (B) or GluN1-1a/2A/3B (C) and exposed to 100 μM NMDA plus 10 μM Gly with the addition of increasing concentrations of MK-801 (10â 8 to 10â 4 M in 10-fold increments) indicated by the arrows, with the last arrow indicating wash. Traces begin 3 s before the lowest MK-801 concentration was applied by which point a stable current was established; as this was after a variable period the first part of the trace is not shown. All traces were recorded at a Vh of â 75 mV. DâF, concentrationâinhibition curves for MK-801 block of 100 μM NMDA plus 10 μM Gly currents from Xenopus oocytes injected with GluN1-1A/2A (â, solid line), GluN1-1a/2A/3A (â , broken line) or GluN1-1a/2A/3B (â¦, dotted line). Points are means ± S.E.M. for 5â7 oocytes. Curves are fits to the equation given in the Materials and methods section and IC50s derived from these are given in Fig. 3.
|
|
Fig. 7. Characterising the block of GluN3-lacking and GluN3-containing NMDA receptors by PhTX-343. AâC, sample traces of currents from Xenopus oocytes injected with GluN1-1A/2A (A), GluN1-1a/2A/3A (B) or GluN1-1a/2A/3B (C) and exposed to 100 μM NMDA plus 10 μM Gly with the addition of increasing concentrations of PhTX-343 (10â 8 to 10â 4 M in 10-fold increments) indicated by the arrows, with the last arrow indicating wash. Traces begin 3 s before the lowest PhTX-343 concentration was applied by which point a stable current was established; as this was after a variable period the first part of the trace is not shown. All traces were recorded at a Vh of â 75 mV. DâF, concentrationâinhibition curves for PhTX-343 block of 100 μM NMDA plus 10 μM Gly currents from Xenopus oocytes injected with GluN1-1A/2A (â, solid line), GluN1-1a/2A/3A (â , broken line) or GluN1-1a/2A/3B (â¦, dotted line). Points are means ± S.E.M. for 6â11 oocytes. Curves are fits to the equation given in the Materials and methods section and IC50s derived from these are given in Fig. 3.
|
|
Fig. 8. Characterising the block of GluN3-lacking and GluN3-containing NMDA receptors by methoctramine. AâC, sample traces of currents from Xenopus oocytes injected with GluN1-1A/2A (A), GluN1-1a/2A/3A (B) or GluN1-1a/2A/3B (C) and exposed to 100 μM NMDA plus 10 μM Gly with the addition of increasing concentrations of methoctramine (10â 8 to 10â 4 M in 10-fold increments) indicated by the arrows, with the last arrow indicating wash. Traces begin 3 s before the lowest methoctramine concentration was applied by which point a stable current was established; as this was after a variable period the first part of the trace is not shown. All traces were recorded at a Vh of â 75 mV. D-F, concentrationâinhibition curves for methoctramine block of 100 μM NMDA plus 10 μM Gly currents from Xenopus oocytes injected with GluN1-1A/2A (â, solid line), GluN1-1a/2A/3A (â , broken line) or GluN1-1a/2A/3B (â¦, dotted line). Points are means ± S.E.M. for 5â8 oocytes. Curves are fits to the equation given in the Materials and methods section and IC50s derived from these are given in Fig. 3.
|